X A-DERM
Live / Applied — Statement of use — registration review complete (as of 17 Aug 2026)
What this means for you
Not registered yet, but its 06 Jun 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98587298
- Mark type
- Stylized text
- Filed
- 06 Jun 2024
- Published for opposition
- 06 May 2025
- Attorney of record
- Matthew T. Kramer
Goods and services
- Class 005 — Pharmaceuticals: Tissue-based products, namely, biological tissue grafts for use in dental, medical, and surgical procedures and applications; Pharmaceutical preparations and substances, namely, biological tissue grafts for use in regenerative medicine, wound repair, and surgical repair; Wound healing system, namely, biological tissue grafting materials for use in regenerative medicine, wound repair, and surgical repair; Biological tissue grafts used in combination with surgical implants for use in soft tissue reconstruction
Owner
- CellTherX Corp, Dallas, TX, US
- CellTherX Corp, Dallas, TX, US
Prosecution history
- 08 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 17 Aug 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Aug 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Jul 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Jul 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Jul 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 06 Jul 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 06 Jul 2026 — FINAL REFUSAL E-MAILED
- 06 Jul 2026 — SU - FINAL REFUSAL - WRITTEN
- 21 May 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 May 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 May 2026 — ASSIGNED TO LIE
- 19 May 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED